GlassScriptPhysician profile
Jared Michael Chow
NPI 1518481704
$2,109.04
in general payments reported to CMS, 2019-2025
29 companies · $626 in 2025
The $626 reported for 2025 was more than what 75% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $643 · 2022: $298 · 2023: $203 · 2024: $339 · 2025: $626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,141 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15.23 · Education: $12.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,140.78 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15.23 |
| Education | $12.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Springworks Therapeutics, INC. | $348.89 | 2025 | Gomekli |
| Pharmacyclics LLC, An Abbvie Company | $225.08 | 2021-2023 | Imbruvica, Epkinly |
| Abbvie INC. | $165.63 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $145.98 | 2022 | |
| Gilead Sciences, INC. | $108.00 | 2022 | |
| Alexion Pharmaceuticals, INC. | $102.15 | 2021-2024 | Ultomiris |
| Astellas Pharma US INC | $95.00 | 2021 | |
| Stryker Corporation | $87.21 | 2021 | |
| Merz Pharmaceuticals, LLC | $82.39 | 2023-2024 | Xeomin |
| Array Biopharma INC | $72.87 | 2021-2025 | Braftovi, Mektovi, Lorbrena |
| Bayer Healthcare Pharmaceuticals INC. | $66.81 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $62.61 | 2021-2024 | Enhertu, Andexxa |
| Medtronic, INC. | $55.94 | 2024 | Percept PC Brainsense |
| Kyowa Kirin, INC. | $49.72 | 2021-2022 | |
| Axogen | $48.34 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $43.65 | 2021-2024 | |
| Jazz Pharmaceuticals INC. | $41.77 | 2025 | |
| Novocure INC. | $35.72 | 2023-2024 | Optune |
| Ipsen Biopharmaceuticals, INC | $33.65 | 2024 | Dysport |
| Mdd US Operations, LLC | $31.50 | 2025 | |
| Catalyst Pharmaceuticals, INC. | $29.48 | 2021 | |
| Caris Mpi, INC. | $28.33 | 2025 | Mi Cancer Seek |
| Sk Life Science, INC. | $23.75 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $23.69 | 2021 | |
| Adamas Pharmaceuticals, INC. | $23.19 | 2021 | |
| Celgene Corporation | $22.71 | 2021 | |
| Neurelis, INC. | $20.47 | 2021 | |
| Microtransponder, INC. | $19.79 | 2023 | |
| Daiichi Sankyo INC. | $14.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Chow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.